SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 57.81 |
Enterprise Value ($M) | -26.90 |
Book Value ($M) | 151.13 |
Book Value / Share | 3.56 |
Price / Book | 0.38 |
NCAV ($M) | 145.77 |
NCAV / Share | 3.43 |
Price / NCAV | 0.40 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.55 |
Return on Assets (ROA) | -0.32 |
Return on Equity (ROE) | -0.37 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 6.77 |
Current Ratio | 6.77 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 171.15 |
Assets | 176.51 |
Liabilities | 25.38 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 53.48 |
Operating Income | -92.14 |
Net Income | -84.69 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -76.44 |
Cash from Investing | 49.47 |
Cash from Financing | 0.54 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | ARK Investment Management LLC | 4.70 | -29.12 | |
13D/A | MPM BioVentures 2014, L.P. | 4.60 | ||
13G/A | Deep Track Capital, LP | 0.00 | -100.00 | |
13G/A | Redmile Group, LLC | 4.60 | -9.60 | |
13G/A | Blue Owl Capital Holdings LP | 7.93 | 8.01 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
46,064 | 109,721 | 41.98 | |
47,870 | 200,859 | 23.83 | |
164,014 | 645,259 | 25.42 | |
16,523 | 139,226 | 11.87 | |
(click for more detail) |
Similar Companies | |
---|---|
RLYB – Rallybio Corporation | ROIV – Roivant Sciences Ltd. |
RPRX – Royalty Pharma plc | RVMD – Revolution Medicines, Inc. |
RXRX – Recursion Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io